ad-sig-hmuc-1/ecdcd40l vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00706615)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad-sig-hmuc-1/ecdcd40l vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02140996 | Phase 1 | Sep 1, 2014 | ClinDatrix, Inc., Government of Singapore, MicroVAX, LLC, Singapore Clinical Research Institute |
| NCT00706615 | Phase 1 | Jul 1, 2008 | National Cancer Institute (NCI), University of California, Los Angeles |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ClinDatrix, Inc. | For profit | 1 | 0 | 1 | 2014 |
| Government of Singapore | Government | 1 | 0 | 1 | 2014 |
| MicroVAX, LLC | For profit | 1 | 0 | 1 | 2014 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2008 |
| Singapore Clinical Research Institute | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2008 |
6 organizations
Page 1 / 1